Seizures following COVID ‐19 vaccination in Mexico: A nationwide observational study

Author:

Núñez Isaac1ORCID,García‐Grimshaw Miguel2ORCID,Castillo Valencia Carlos Yoel3,Aguilera Callejas Daniel Eduardo3,Moya Alfaro Mónica Libertad3,Saniger‐Alba María del Mar2,Gutiérrez‐Romero Alonso3,Carrillo‐Mezo Roger3,Ceballos‐Liceaga Santa Elizabeth4,Baptista‐Rosas Raúl C.56,López‐Gatell Hugo7,Reyes‐Terán Gustavo8,Díaz‐Ortega Jose Luis9,Arauz Antonio3ORCID,Valdés‐Ferrer Sergio Iván2ORCID,Hernández‐Vanegas Laura E.3ORCID

Affiliation:

1. Department of Medical Education Salvador Zubirán National Institute of Medical Sciences and Nutrition Mexico City Mexico

2. Department of Neurology and Psychiatry Salvador Zubirán National Institute of Medical Sciences and Nutrition Mexico City Mexico

3. Department of Neurology National Institute of Neurology and Neurosurgery Mexico City Mexico

4. Directorate‐General for Epidemiology, Ministry of Health Mexico City Mexico

5. Department of Health Sciences–Disease as an Individual Process, University Center of Tonalá University of Guadalajara Guadalajara Mexico

6. Critical Medicine Intervention Unit, Western General Hospital Jalisco Ministry of Health Zapopan Mexico

7. Undersecretary of Prevention and Health Promotion Ministry of Health Mexico City Mexico

8. Coordinating Commission of National Institutes of Health and High Specialty Hospitals Ministry of Health Mexico City Mexico

9. National Center for Child and Adolescent Health Ministry of Health Mexico City Mexico

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference21 articles.

1. The lightning-fast quest for COVID vaccines — and what it means for other diseases

2. Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity

3. Approved COVID‐19 vaccines in Mexico. Ministry of Health Mexico[cited 2022 Jun 10]. Available from:http://vacunacovid.gob.mx/wordpress/informacion‐de‐la‐vacuna/

4. Surveillance for Adverse Events After COVID-19 mRNA Vaccination

5. World Health Organization.Global manual on surveillance of adverse events following immunization. [cited 2022 Jun 10]. Available from:https://apps.who.int/iris/rest/bitstreams/914830/retrieve

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3